Novartis to acquire Avidity Biosciences for about $12 billion
(Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion…
(Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion…
(Removes last paragraph duplication) By Sabrina Valle NEW YORK (Reuters) -JPMorgan Chase & Co has poached three senior investment bankers…